secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001437749-25-020579
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma posts updated investor presentation highlighting EXXUA opportunity
--------------------------------------------------------------------------------

- Presentation posted on June 17, 2025 for use in upcoming investor meetings.
- Highlights EXXUA™ (gepirone) extended-release tablets as a key pipeline asset.
- No new financial guidance, operational metrics, or material events disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000143774925020579/0001437749-25-020579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000143774925020579/aytu20250616_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer